Perelman School of Medicine

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660December 10, 2014

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

blurb: 
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Cutting Docs-in-Training Hours Hasn't Improved Patient Care: Studies

December 9, 2014

Perelman School of Medicine’s Mitesh Patel is quoted about a Penn study on doctor fatigue and patient care.

Article Source: Philadelphia Inquirer

Special K, a Hallucinogen, Raises Hopes and Concerns as a Treatment for Depression

December 9, 2014

Dominic A. Sisti of the Perelman School of Medicine shares his opinion on using hallucinogenic drugs to treat depression.

Article Source: New York Times
facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659December 8, 2014

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

blurb: 
Findings Include Response Rates Over 90 Percent in Pediatric Acute Lymphoblastic Leukemia, and First Results of Non-Hodgkin Lymphoma Trial

The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.

Audio: Penn Scientists Find Way to Prevent Memory Loss After Sleep Deprivation

December 8, 2014
Robbert Havekes of the Perelman School of Medicine comments on how lack o
Article Source: Newsworks

Check Up: Penn Research Offers Hope of Finding Concussion Marker

December 7, 2014
Robert Siman of the Perelman School of Medicine is quoted on his study to identify concussion danger via blood test. 
Article Source: Philadelphia Inquirer
facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653December 3, 2014

Brain Activity after Smokers Quit Predicts Chances of Relapsing, Penn Medicine Study Suggests

Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today’s clinical or behavioral tools for assessing relapse risk.

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653December 4, 2014

People with Mental Illness More Likely To Be Tested for HIV, Penn Medicine Study Finds

People with mental illness are more likely to have been tested for HIV than those without mental illness, according to a 

Scientists Identify Brain Regions That May Predict Success Rate for Quitting Smoking

December 3, 2014

Caryn Lerman of the Perelman School of Medicine talks about researching regions of the brain that may help predict succ

Article Source: Fox News

Penn Scientists Identify Possible Key to Gauging Extent of Concussion

November 27, 2014

Bob Siman of the Perelman School of Medicine discusses a protein, SNTF, which might be able to predict the severity of